Is Covaxin safe for children? Here's what Bharat Biotech has to say

Bharat Biotech International Ltd on Friday said its COVID-19 vaccine Covaxin has proven to be safe, well-tolerated and highly immunogenic in children and adolescents of 2-18 years age group in phase II/III study.

Related Keywords

India ,New Delhi ,Delhi ,Bharat ,Krishna Ella ,Bharat Biotech International Ltd On ,Bharat Biotech International Ltd ,Central Drugs Standard Control Organisation ,Lancet Infectious ,Biotech Chairman , ,